Sir Chris Hoy has said he is hopeful that new trial drugs could extend his life, as he continues treatment for stage 4 prostate cancer. The six-time Olympic gold medalist was diagnosed in 2023 and given between two and four years to live.
The 50-year-old spoke on Track Radio ahead of its launch on May 4, describing how he takes each scan and blood test as it comes. He said the current medication is working, but when it stops, he will switch to another treatment. However, he highlighted “really exciting new drugs” in trials that have shown “really impressive results,” and could be available for standard treatment in a year or two.
Hoy also discussed The Tour de 4, a charity cycling event he launched this year. The initiative has already raised £3.1 million. He said the goal is to help future generations and to provide support for those going through difficult times, adding that the event is a way to “make the best of a very difficult situation.”
Hoy, who was Britain’s most successful Olympian until 2021, has continued to raise awareness about cancer and screenings. He said “cancer affects everybody” and that collective action can make a difference for the future.
